# FDA Inspection 1067952 - Stason Pharmaceuticals, Inc. - August 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/c461b407-5ab8-41b5-85e0-c65492b60648
Source feed: FDA_Inspections

> FDA Inspection 1067952 for Stason Pharmaceuticals, Inc. on August 24, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067952
- Company Name: Stason Pharmaceuticals, Inc.
- Inspection Date: 2018-08-24
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1140029 - 2021-04-13](https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/e008c2db-1a3a-4777-a1d4-95639363fad5)
- [FDA Inspection 1109969 - 2019-10-25](https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/90ef0808-a961-4985-b357-a157bccefec0)
- [FDA Inspection 960658 - 2016-03-08](https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/159d119e-bf2e-4798-8edf-f4e295f131e8)
- [FDA Inspection 911418 - 2015-01-22](https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/f988509a-4e29-445c-b5e9-173ef0e4eb50)
- [FDA Inspection 859439 - 2013-12-18](https://www.keypedia.com/records/fda_inspections/stason-pharmaceuticals-inc/4a4f0714-3266-43d0-9538-b8d8c15a7c0a)

Company: https://www.keypedia.com/companies/stason-pharmaceuticals-inc/f8669d38-d60b-4f0c-856a-ac536c422fae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c